Neovacs S.A. (ALNEV) — Free Cash Flow Generation Index
Latest as of December 2023:
0.90x
Neovacs S.A. (ALNEV) has a Free Cash Flow Generation Index of 0.90x as of December 2023. Free cash flow of €1.32 Million represents 1% of operating cash flow (€1.47 Million). See Neovacs S.A. (ALNEV) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
0.90x
Free Cash Flow / Operating CF
Free Cash Flow
€1.32 Million
EUR
Operating Cash Flow
€1.47 Million
EUR
Capital Expenditures
€150.45K
EUR
Annual Free Cash Flow Generation for Neovacs S.A. (None–None)
Year-by-year Free Cash Flow Generation Index for Neovacs S.A.. For the full company profile including market capitalisation, see Neovacs S.A. stock valuation.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).